Avastin, one of the world’s most popular cancer drugs, has been under intense scrutiny by the FDA while the agency works to determine whether or not to pull its approval of the drug as a treatment for breast cancer. In an effort to save one of its best-selling products, the drug’s manufacturer, Roche, has asked [...]
